Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their Research

by Charles Ornstein and Ryann Grochowski Jones   ProPublica,  March 25, 2014, 12 a.m.  This story was co-published with The Boston Globe.  Research has been seen as less objectionable than other forms of interactions with drug companies, but 10 percent of researchers have multiple ties among the nine companies ProPublica analyzed. That raises questions about doctors’ impartiality.  A ProPublica analysis shows that more than 1,300 practitioners nationwide received both research money and speaking or consulting fees from the same drug maker in 2012. All told, they received more than $90 million in research grants — plus nearly $13 million for speaking engagements and another $4 million for consulting.  Read more